Skip to main content

Table 4 Percentage Reduction in Study Variables

From: Liraglutide and Dulaglutide therapy in addition to SGLT-2 inhibitor and metformin treatment in Indian type 2 diabetics: a real world retrospective observational study

Study Variables

Liraglutide, N = 30

Dulaglutide, N = 30

p

Percent Change in Body weight

Mean ± SEM

−5.83 ± 0.87

−4.2 ± 0.46

0.103

Percent Change in BMI, Mean ± SEM

−2.27 ± 0.33

1.53 ± 0.20

0.061

Percent Change in SBP, Mean ± SEM

−10.23 ± 2.36

−3.43 ± 2.98

0.079

Percent Change in DBP, Mean ± SEM

−2.8 ± 1.85

−2.3 ± 1.79

0.847

Percent Change in FPG, Mean ± SEM

−44.2 ± 8.05

−41.87 ± 12.72

0.877

Percent Change in HbA1c, Mean ± SEM

− 1.55 ± 0.22

−1.02 ± 0.22

0.091